Matrix metalloproteinases at cancer tumor-host interface

[en] The increasing diversity in both substrates and functions of matrix metalloproteinases (MMPs) makes these enzymes central regulators in the complex tumor ecosystem composed of cancer cells and their microenvironment. In the majority of cancers, membrane-associated and extracellular proteases are mainly produced by host cells including inflammatory cells, endothelial cells, pericytes and fibroblasts. Recent data based on in vitro and in vivo studies have demonstrated the relevance of these enzymes in multiple processes controlling cancer growth, angiogenesis and metastatic dissemination. This review will present the emerging MMP-related features of cancer cells and host cells.

Disciplines :

Biochemistry, biophysics & molecular biology

Author, co-author :

Noël, Agnès ; Université de Liège - ULiège > Département des sciences biomédicales et précliniques > Biologie cellulaire et moléculaire appliquée à l'homme

Jost, M.

Maquoi, Erik ; Université de Liège - ULiège > Département des sciences cliniques > Labo de biologie des tumeurs et du développement

Language :

English

Title :

Matrix metalloproteinases at cancer tumor-host interface

Publication date :

2008

Journal title :

Seminars in Cell and Developmental Biology

ISSN :

1084-9521

eISSN :

1096-3634

Publisher :

Academic Press, London, United Kingdom

Volume :

Pages :

52-60

Peer reviewed :

Peer Reviewed verified by ORBi

Available on ORBi :

since 16 June 2009

Statistics

Number of views

178 (16 by ULiège)

Number of downloads

508 (3 by ULiège)

More statistics

Scopus citations^®

209

Scopus citations^®
without self-citations

187

OpenCitations

169

OpenAlex citations

237

Bibliography

Vogelstein B., and Kinzler K.W. Cancer genes and the pathways they control. Nat Med 10 (2004) 789-799
Fidler I.J. The pathogenesis of cancer metastasis: the "seed and soil" hypothesis revisited. Nat Rev Cancer 3 (2003) 453-458
Albini A., and Sporn M.B. The tumour microenvironment as a target for chemoprevention. Nat Rev Cancer 7 (2007) 139-147
Sternlicht M.D., and Werb Z. How matrix metalloproteinases regulate cell behavior. Annu Rev Cell Dev Biol 17 (2001) 463-516
Mueller M.M., and Fusenig N.E. Friends or foes-bipolar effects of the tumour stroma in cancer. Nat Rev Cancer 4 (2004) 839-849
Tlsty T.D., and Hein P.W. Know thy neighbor: stromal cells can contribute oncogenic signals. Curr Opin Genet Dev 11 (2001) 54-59
Mareel M., and Leroy A. Clinical, cellular, and molecular aspects of cancer invasion. Physiol Rev 83 (2003) 337-376
Overall C.M., and Kleifeld O. Tumour microenvironment-opinion-validating matrix metalloproteinases as drug targets and anti-targets for cancer therapy. Nat Rev Cancer 6 (2006) 227-239
Egeblad M., and Werb Z. New functions for the matrix metalloproteinases in cancer progression. Nat Rev Cancer 2 (2002) 161-174
Overall C.M., and Lopez-Otin C. Strategies for MMP inhibition in cancer: innovations for the post-trial era. Nat Rev Cancer 2 (2002) 657-672
Folgueras A.R., Pendas A.M., Sanchez L.M., and Lopez-Otin C. Matrix metalloproteinases in cancer: from new functions to improved inhibition strategies. Int J Dev Biol 48 (2004) 411-424
Page-McCaw A., Ewald A.J., and Werb Z. Matrix metalloproteinases and the regulation of tissue remodelling. Nat Rev Mol Cell Biol 8 (2007) 221-233
Visse R., and Nagase H. Matrix metalloproteinases and tissue inhibitors of metalloproteinases: structure, function, and biochemistry. Circ Res 92 (2003) 827-839
Brew K., Dinakarpandian D., and Nagase H. Tissue inhibitors of metalloproteinases: evolution, structure and function. Biochim Biophys Acta 1477 (2000) 267-283
Murphy G., Knauper V., Lee M.H., Amour A., Worley J.R., Hutton M., et al. Role of TIMPs (tissue inhibitors of metalloproteinases) in pericellular proteolysis: the specificity is in the detail. Biochem Soc Symp 70 (2003) 65-80
Noel A., Maillard C., Rocks N., Jost M., Chabottaux V., Sounni N.E., et al. Membrane associated proteases and their inhibitors in tumour angiogenesis. J Clin Pathol 57 (2004) 577-584
Sounni N.E., and Noel A. Membrane type-matrix metalloproteinases and tumor progression. Biochimie 87 (2005) 329-342
Ii M., Yamamoto H., Adachi Y., Maruyama Y., and Shinomura Y. Role of matrix metalloproteinase-7 (matrilysin) in human cancer invasion, apoptosis, growth, and angiogenesis. Exp Biol Med 231 (2006) 20-27
Jost M., Folgueras A.R., Frerart F., Pendas A.M., Blacher S., Houard X., et al. Earlier onset of tumoral angiogenesis in matrix metalloproteinase-19-deficient mice. Cancer Res 66 (2006) 5234-5241
Balbin M., Fueyo A., Tester A.M., Pendas A.M., Pitiot A.S., Astudillo A., et al. Loss of collagenase-2 confers increased skin tumor susceptibility to male mice. Nat Genet 35 (2003) 252-257
Rio M.C. From a unique cell to metastasis is a long way to go: clues to stromelysin-3 participation. Biochimie 87 (2005) 299-306
Ramaswamy S., Ross K.N., Lander E.S., and Golub T.R. A molecular signature of metastasis in primary solid tumors. Nat Genet 33 (2003) 49-54
van't Veer L.J., Dai H.Y., van de Vijver M.J., He Y.D.D., Hart A.A.M., Mao M., et al. Gene expression profiling predicts clinical outcome of breast cancer. Nature 415 (2002) 530-536
Minn A.J., Gupta G.P., Siegel P.M., Bos P.D., Shu W.P., Giri D.D., et al. Genes that mediate breast cancer metastasis to lung. Nature 436 (2005) 518-524
Gupta G.P., Nguyen D.X., Chiang A.C., Bos P.D., Kim J.Y., Nadal C., et al. Mediators of vascular remodelling co-opted for sequential steps in lung metastasis. Nature 446 (2007) 765-770
Kaplan R.N., Riba R.D., Zacharoulis S., Bramley A.H., Vincent L., Costa C., et al. VEGFR1-positive haematopoietic bone marrow progenitors initiate the pre-metastatic niche. Nature 438 (2005) 820-827
Kaplan R.N., Rafii S., and Lyden D. Preparing the "Soil": the premetastatic niche. Cancer Res 66 (2006) 11089-11093
Hiratsuka S., Watanabe A., Aburatani H., and Maru Y. Tumour-mediated upregulation of chemoattractants and recruitment of myeloid cells predetermines lung metastasis. Nat Cell Biol 8 (2006) 1369-1375
Hiratsuka S., Nakamura K., Iwai S., Murakami M., Itoh T., Kijima H., et al. MMP9 induction by vascular endothelial growth factor receptor-1 is involved in lung-specific metastasis. Cancer Cell 2 (2002) 289-300
Skoog T., Ahokas K., Orsmark C., Jeskanen L., Isaka K., and Saarialho-Kere U. MMP-21 is expressed by macrophages and fibroblasts in vivo and in culture. Exp Dermatol 15 (2006) 775-783
Harrell P.C., McCawley L.J., Fingleton B., McIntyre J.O., and Matrisian L.M. Proliferative effects of apical, but not basal, matrix metalloproteinase-7 activity in polarized MDCK cells. Exp Cell Res 303 (2005) 308-320
Yu W.H., Woessner Jr. J.F., McNeish J.D., and Stamenkovic I. CD44 anchors the assembly of matrilysin/MMP-7 with heparin-binding epidermal growth factor precursor and ErbB4 and regulates female reproductive organ remodeling. Genes Dev 16 (2002) 307-323
Noe V., Fingleton B., Jacobs K., Crawford H.C., Vermeulen S., Steelant W., et al. Release of an invasion promoter E-cadherin fragment by matrilysin and stromelysin-1. J Cell Sci 114 (2001) 111-118
Powell W.C., Fingleton B., Wilson C.L., Boothby M., and Matrisian L.M. The metalloproteinase matrilysin proteolytically generates active soluble Fas ligand and potentiates epithelial cell apoptosis. Curr Biol 9 (1999) 1441-1447
Djonov V., Hogger K., Sedlacek R., Laissue J., and Draeger A. MMP-19: cellular localization of a novel metalloproteinase within normal breast tissue and mammary gland tumours. J Pathol 195 (2001) 147-155
Impola U., Toriseva M., Suomela S., Jeskanen L., Hieta N., Jahkola T., et al. Matrix metalloproteinase-19 is expressed by proliferating epithelium but disappears with neoplastic dedifferentiation. Int J Cancer 103 (2003) 709-716
Pendas A.M., Folgueras A.R., Llano E., Caterina J., Frerard F., Rodriguez F., et al. Diet-induced obesity and reduced skin cancer susceptibility in matrix metalloproteinase 19-deficient mice. Mol Cell Biol 24 (2004) 5304-5313
Gilles C., Newgreen D.F., Sato H., and Thompson E.W. Matrix metalloproteases and epithelial-to-mesenchymal transition: implications for carcinoma metastasis. In: Savagner P. (Ed). Rise and Fall of Epithelial Phenotype (2004), Eurokah.com and Kluwer Academic/Plenum Publishers, New York 233-251
Lohi J., Wilson C.L., Roby J.D., and Parks W.C. Epilysin, a novel human matrix metalloproteinase (MMP-28) expressed in testis and keratinocytes and in response to injury. J Biol Chem 276 (2001) 10134-10144
Illman S.A., Lehti K., Keski-Oja J., and Lohi J. Epilysin (MMP-28) induces TGF-beta mediated epithelial to mesenchymal transition in lung carcinoma cells. J Cell Sci 119 (2006) 3856-3865
Friedl P., and Wolf K. Tumour-cell invasion and migration: diversity and escape mechanisms. Nat Rev Cancer 3 (2003) 362-374
Hotary K., Li X.Y., Allen E., Stevens S.L., and Weiss S.J. A cancer cell metalloprotease triad regulates the basement membrane transmigration program. Genes Dev 20 (2006) 2673-2686
Lambert V., Wielockx B., Munaut C., Galopin C., Jost M., Itoh T., et al. MMP-2 and MMP-9 synergize in promoting choroidal neovascularization. FASEB J 17 (2003) 2290-2292
Masson V., de la Ballina L.R., Munaut C., Wielockx B., Jost M., Maillard C., et al. Contribution of host MMP-2 and MMP-9 to promote tumor vascularization and invasion of malignant keratinocytes. FASEB J 18 (2005) 234
Chabottaux V., Sounni N.E., Pennington C.J., English W.R., van den Brule F., Blacher S., et al. Membrane-type 4 matrix metalloproteinase promotes breast cancer growth and metastases. Cancer Res 66 (2006) 5165-5172
Zigrino P., Loffek S., and Mauch C. Tumor-stroma interactions: their role in the control of tumor cell invasion. Biochimie 87 (2005) 321-328
Ala-Aho R., and Kahari V.M. Collagenases in cancer. Biochimie 87 (2005) 273-286
Bisson C., Blacher S., Polette M., Blanc J.F., Kebers F., Desreux J., et al. Restricted expression of membrane type 1-matrix metalloproteinase by myofibroblasts adjacent to human breast cancer cells. Int J Cancer 105 (2003) 7-13
Sternlicht M.D., Lochter A., Sympson C.J., Huey B., Rougler J.P., Gray J.W., et al. The stromal proteinase MMP3/stromelysin-1 promotes mammary carcinogenesis. Cell 98 (1999) 137-146
Basset P., Bellocq J.P., Wolf C., Stoll I., Hutin P., Limacher J.M., et al. A novel metalloproteinase gene specifically expressed in stromal cells of breast carcinomas. Nature 348 (1990) 699-704
Zucker S., Pei D., Cao J., and Lopez-Otin C. Membrane type-matrix metalloproteinases (MT-MMP). Curr Top Dev Biol 54 (2003) 1-74
Polette M., and Birembaut P. Membrane-type metalloproteinases in tumor invasion. Int J Biochem Cell Biol 30 (1998) 1195-1202
Brooks P.C., Stromblad S., Sanders L.C., von Schalscha T.L., Aimes R.T., Stetler-Stevenson W.G., et al. Localization of matrix metalloproteinase MMP-2 to the surface of invasive cells by interaction with integrin alpha v beta 3. Cell 85 (1996) 683-693
Johansson N., Vaalamo M., Grenman S., Hietanen S., Klemi P., Saarialho-Kere U., et al. Collagenase-3 (MMP-13) is expressed by tumor cells in invasive vulvar squamous cell carcinomas. Am J Pathol 154 (1999) 469-480
Boulay A., Masson R., Chenard M.P., El Fahime M., Cassard L., Bellocq J.P., et al. High cancer cell death in syngeneic tumors developed in host mice deficient for the stromelysin-3 matrix metalloproteinase. Cancer Res 61 (2001) 2189-2193
Noel A., and Foidart J.M. The role of extracellular matrix and fibroblasts in breast carcinoma growth in vivo. J Mammary Gland Biol Neoplasia 3 (1998) 215-225
Noel A., Hajitou A., L'Hoir C., Maquoi E., Baramova E., Lewalle J.M., et al. Inhibition of stromal matrix metalloproteases: effects on breast-tumor promotion by fibroblasts. Int J Cancer 76 (1998) 267-273
Masson R., Lefebvre O., Noel A., El Fahime M., Chenard M.P., Wendling C., et al. In vivo evidence that the stromelysin-3 metalloproteinase contributes in a paracrine manner to epithelial cell malignancy. J Cell Biol 140 (1998) 1535-1541
Zhang W.Y., Matrisian L.M., Holmbeck K., Vick C.C., and Rosenthal E.L. Fibroblast-derived MT1-MMP promotes tumor progression in vitro and in vivo. BMC Cancer 6 (2006)
Bavik C., Coleman I., Dean J.P., Knudsen B., Plymate S., and Nelson P.S. The gene expression program of prostate fibroblast senescence modulates neoplastic epithelial cell proliferation through paracrine mechanisms. Cancer Res 66 (2006) 794-802
Liu D., and Hornsby P.J. Senescent human fibroblasts increase the early growth of xenograft tumors via matrix metalloproteinase secretion. Cancer Res 67 (2007) 3117-3126
Radisky D.C., Levy D.D., Littlepage L.E., Liu H., Nelson C.M., Fata J.E., et al. Rac1b and reactive oxygen species mediate MMP-3-induced EMT and genomic instability. Nature 436 (2005) 123-127
Pollard J.W. Tumour-educated macrophages promote tumour progression and metastasis. Nat Rev Cancer 4 (2004) 71-78
Mantovani A., Bottazzi B., Colotta F., Sozzani S., and Ruco L. The origin and function of tumor-associated macrophages. Immunol Today 13 (1992) 265-270
Leek R.D., Lewis C.E., Whitehouse R., Greenall M., Clarke J., and Harris A.L. Association of macrophage infiltration with angiogenesis and prognosis in invasive breast carcinoma. Cancer Res 56 (1996) 4625-4629
Torisu H., Ono M., Kiryu H., Furue M., Ohmoto Y., Nakayama J., et al. Macrophage infiltration correlates with tumor stage and angiogenesis in human malignant melanoma: possible involvement of TNF alpha and IL-1 alpha. Int J Cancer 85 (2000) 182-188
Lin E.Y., Nguyen A.V., Russell R.G., and Pollard J.W. Colony-stimulating factor 1 promotes progression of mammary tumors to malignancy. J Exp Med 193 (2001) 727-739
Robinson S.C., Scott K.A., and Balkwill F.R. Chemokine stimulation of monocyte matrix metalloproteinase-9 requires endogenous TNF-alpha. Eur J Immunol 32 (2002) 404-412
Huang S.Y., Van Arsdall M., Tedjarati S., McCarty M., Wu W.J., Langley R., et al. Contributions of stromal metalloproteinase-9 to angiogenesis and growth of human ovarian carcinoma in mice. J Natl Cancer Inst 94 (2002) 1134-1142
Dong Z., Kumar R., Yang X., and Fidler I.J. Macrophage-derived metalloelastase is responsible for the generation of angiostatin in Lewis lung carcinoma. Cell 88 (1997) 801-810
Cornelius L.A., Nehring L.C., Harding E., Bolanowski M., Welgus H.G., Kobayashi D.K., et al. Matrix metalloproteinases generate angiostatin: effects on neovascularization. J Immunol 161 (1998) 6845-6852
Houghton A.M., Grisolano J.L., Baumann M.L., Kobayashi D.K., Hautamaki R.D., Nehring L.C., et al. Macrophage elastase (matrixmetalloproteinase-12) suppresses growth of lung metastases. Cancer Res 66 (2006) 6149-6155
Kankkunen J.P., HArvima I.T., and Naukkarinen A. Quantitative analysis of tryptase and chymase containing mast cells in benign and malignant breast lesions. Int J Cancer 72 (1997) 385-388
Duncan L.M., Richards L.A., and Mihm M.C. Increased mast cell density in invasive melanoma. J Cutan Pathol 25 (1998) 11-15
Roche W.R. The nature and significance of tumour-associated mast cells. J Pathol 148 (1986) 175-182
Coussens L.M., Raymond W.W., Bergers G., Laig-Webster M., Behrendtsen O., Werb Z., et al. Inflammatory mast cells up-regulate angiogenesis during squamous epithelial carcinogenesis. Genes Dev 13 (1999) 1382-1397
Coussens L.M., Tinkle C.L., Hanahan D., and Werb Z. MMP-9 supplied by bone marrow-derived cells contributes to skin carcinogenesis. Cell 103 (2000) 481-490
Scott K.G. The mast cell, its amines, and tumor growth in rodents and man. Ann NY Acad Sci 103 (1963) 285-312
Fang K.C., Wolters P.J., Steinhoff M., Bidgol A., Blount J.L., and Caughey G.H. Mast cell expression of gelatinases A and B is regulated by kit ligand and TGF-beta. J Immunol 162 (1999) 5528-5535
Gruber B.L., Marchese M.J., Suzuki K., Schwartz L.B., Okada Y., Nagase H., et al. Synovial procollagenase activation by human mast-cell tryptase dependence upon matrix metalloproteinase-3 activation. J Clin Invest 84 (1989) 1657-1662
Bergers G., Brekken R., McMahon G., Vu T.H., Itoh T., Tamaki K., et al. Matrix metalloproteinase-9 triggers the angiogenic switch during carcinogenesis. Nat Cell Biol 2 (2000) 737-744
Van Lint P., and Libert C. Matrix metalloproteinase-8: cleavage can be decisive. Cytokine Growth Factor Rev 17 (2006) 217-223
Tester AM, Cox JH, Connor AR, Starr AE, Dean RA, Puente XS et al. LPS Responsiveness and neutrophil chemotaxis in vivo require PMN MMP-8 activity. PLoS ONE 2007;March 2007:e312.
Carmeliet P. Angiogenesis in life, disease and medicine. Nature 438 (2005) 932-936
Hamano Y., and Kalluri R. Tumstatin, the NC1 domain of alpha 3 chain of type IV collagen, is an endogenous inhibitor of pathological angiogenesis and suppresses tumor growth. Biochem Biophys Res Commun 333 (2005) 292-298
Ferreras M., Felbor U., Lenhard T., Olsen B.R., and Delaisse J. Generation and degradation of human endostatin proteins by various proteinases. FEBS Lett 486 (2000) 247-251
Yu Q., and Stamenkovic I. Cell surface-localized matrix metalloproteinase-9 proteolytically activates TGF-beta and promotes tumor invasion and angiogenesis. Genes Dev 14 (2000) 163-176
Van den Steen P.E., Proost P., Wuyts A., Van Damme J., and Opdenakker G. Neutrophil gelatinase B potentiates interleukin-8 tenfold by aminoterminal processing, whereas it degrades CTAP-III, PF-4, and GRO-alpha and leaves RANTES and MCP-2 intact. Blood 96 (2000) 2673-2681
McQuibban G.A., Butler G.S., Gong J.H., Bendall L., Power C., Clark-Lewis I., et al. Matrix metalloproteinase activity inactivates the CXC chemokine stromal cell-derived factor-1. J Biol Chem 276 (2001) 43503-43508
Hanahan D., and Folkman J. Patterns and emerging mechanisms of the angiogenic switch during tumorigenesis. Cell 86 (1996) 353-364
Oh J., Takahashi R., Adachi E., Kondo S., Kuratomi S., Noma A., et al. Mutations in two matrix metalloproteinase genes, MMP-2 and MT1-MMP, are synthetic lethal in mice. Oncogene 23 (2004) 5041-5048
Holmbeck K., Bianco P., Caterina J., Yamada S., Kromer M., Kuznetsov S.A., et al. MT1-MMP-deficient mice develop dwarfism, osteopenia, arthritis, and connective tissue disease due to inadequate collagen turnover. Cell 99 (1999) 81-92
Zhou Z., Apte S.S., Soininen R., Cao R., Baaklini G.Y., Rauser R.W., et al. Impaired endochondral ossification and angiogenesis in mice deficient in membrane-type matrix metalloproteinase I. Proc Natl Acad Sci USA 97 (2000) 4052-4057
Handsley M.M., and Edwards D.R. Metalloproteinases and their inhibitors in tumor angiogenesis. Int J Cancer 115 (2005) 849-860
Chun T.-H., Sabeh F., Ota I., Murphy H., McDonagh K.T., Holmbeck K., et al. MT1-MMP-dependent neovessel formation within the confines of the three-dimensional extracellular matrix. J Cell Biol 167 (2004) 757-767
Hiraoka N., Allen E., Apel I.J., Gyetko M.R., and Weiss S.J. Matrix metalloproteinases regulate neovascularization by acting as pericellular fibrinolysins. Cell 95 (1998) 365-377
Plaisier M., Kapiteijn K., Koolwijk P., Fijten C., Hanemaaijer R., Grimbergen J.M., et al. Involvement of membrane-type matrix metalloproteinases (MT-MMPs) in capillary tube formation by human endometrial microvascular endothelial cells: role of MT3-MMP. J Clin Endocrinol Metab 89 (2004) 5828-5836
Davis G.E., and Saunders W.B. Molecular balance of capillary tube formation versus regression in wound repair: role of matrix metalloproteinases and their inhibitors. J Invest Dermatol 11 (2006) 44-56
Heissig B., Hattori K., Dias S., Friedrich M., Ferris B., Hackett N.R., et al. Recruitment of stem and progenitor cells from the bone marrow niche requires MMP-9 mediated release of kit-ligand. Cell 109 (2002) 625-637
Chantrain C.F., Shimada H., Jodele S., Groshen S., Ye W., Shalinsky D.R., et al. Stromal matrix metalloproteinase-9 regulates the vascular architecture in neuroblastoma by promoting pericyte recruitment. Cancer Res 64 (2004) 1675-1686
Manes S., Mira E., Barbacid M.D., Cipres A., FernandezResa P., Buesa J.M., et al. Identification of insulin-like growth factor-binding protein-1 as a potential physiological substrate for human stromelysin-3. J Biol Chem 272 (1997) 25706-25712
Sheu B.C., Hsu S.M., No H.N., Tien H.C., Huang S.C., and Lin R.B. A novel role of metalloproteinase in cancer-mediated immunosuppression. Cancer Res 61 (2001) 237-242
Miyamoto S., Nakamura M., Yano K., Ishii G., Hasebe T., Endoh Y., et al. Matrix metalloproteinase-7 triggers the matricrine action of insulin-like growth factor-II via proteinase activity on insulin-like growth factor binding protein 2 in the extracellular matrix. Cancer Sci 98 (2007) 685-691
Overall C.M., McQuibban G.A., and Clark-Lewis I. Discovery of chemokine substrates for matrix metalloproteinases by exosite scanning: a new tool for degradomics. Biol Chem 383 (2002) 1059-1066
Iyengar P., Espina V., Williams T.W., Lin Y., Berry D., Jelicks L.A., et al. Adipocyte-derived collagen VI affects early mammary tumor progression in vivo, demonstrating a critical interaction in the tumor/stroma microenvironment. J Clin Invest 115 (2005) 1163-1176
Mauro L., Catalano S., Bossi G., Pellegrino M., Barone I., Morales S., et al. Evidences that leptin up-regulates E-cadherin expression in breast cancer: effects on tumor growth and progression. Cancer Res 67 (2007) 3412-3421
Klein J., Permana P., Owecki M., Chaldakov G., Bohm M., Hausman G., et al. What are subcutaneous adipocytes really good for?. Exp Dermatol 16 (2007) 45-70
Maquoi E., Munaut C., Colige A., Collen D., and Lijnen H.R. Modulation of adipose tissue expression of murine matrix metalloproteinases and their tissue inhibitors with obesity. Diabetes 51 (2002) 1093-1101
Andarawewa K.L., Motrescu E.R., Chenard M.P., Gansmuller A., Stoll I., Tomasetto C., et al. Stromelysin-3 is a potent negative regulator of adipogenesis participating to cancer cell-adipocyte interaction/crosstalk at the tumor invasive front. Cancer Res 65 (2005) 10862-10871
Deryugina E.I., Ratnikov B.I., Postnova T.I., Rozanov D.V., and Strongin A.Y. Processing of integrin alpha(v) subunit by membrane type 1 matrix metalloproteinase stimulates migration of breast carcinoma cells on vitronectin and enhances tyrosine phosphorylation of focal adhesion kinase. J Biol Chem 277 (2002) 9749-9756
Koshikawa N., Giannelli G., Cirulli V., Miyazaki K., and Quaranta V. Role of cell surface metalloprotease MT1-MMP in epithelial cell migration over laminin-5. J Cell Biol 148 (2000) 615-624
Kajita M., Itoh Y., Chiba T., Mori H., Okada A., Kinoh H., et al. Membrane-type 1 matrix metalloproteinase cleaves CD44 and promotes cell migration. J Cell Biol 153 (2001) 893-904
Belkin A.M., Akimov S.S., Zaritskaya L.S., Ratnikov B.I., Deryugina E.I., and Strongin A.Y. Matrix-dependent proteolysis of surface transglutaminase by membrane-type metalloproteinase regulates cancer cell adhesion and locomotion. J Biol Chem 276 (2001) 18415-18422